Joel Greenblatt acquired 16.4 Thousand Edwards Lifesciences shares worth $1.21 Million. That's 0.01% of their equity portfolio (794th largest holding). The first Edwards Lifesciences trade was made in Q4 2012. Since then Joel Greenblatt bought shares seventeen more times and sold shares on eighteen occasions. The investor's estimated purchase price is $1.49 Million, resulting in a loss of 19%.